S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NASDAQ:BYSI

BeyondSpring Stock Forecast, Price & News

$14.35
+1.07 (+8.06%)
(As of 11/26/2021 04:00 PM ET)
Add
Compare
Today's Range
$13.53
$14.70
50-Day Range
$12.66
$16.84
52-Week Range
$8.90
$33.00
Volume
1.49 million shs
Average Volume
1.20 million shs
Market Capitalization
$561.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.02
30 days | 90 days | 365 days | Advanced Chart
Receive BYSI News and Ratings via Email

Sign-up to receive the latest news and ratings for BeyondSpring and its competitors with MarketBeat's FREE daily newsletter.


BeyondSpring logo

About BeyondSpring

BeyondSpring, Inc. engages in the the development and commercialization of immuno-oncology cancer therapies to improve clinical outcomes for patients who have high unmet medical needs. It operates through PRC and U.S. geographical segments. The company was founded by Lan Huang and Lin Qing Jia in 2013 and is headquartered in New York, NY.

Headlines

BeyondSpring (NASDAQ:BYSI) Shares Gap Up to $13.28
November 26, 2021 |  americanbankingnews.com
BeyondSpring (NASDAQ:BYSI) Stock Price Up 4.3%
November 17, 2021 |  americanbankingnews.com
Circling Back On BeyondSpring - Seeking Alpha
November 16, 2021 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BYSI
Employees
91
Year Founded
N/A

Sales & Book Value

Annual Sales
$180 thousand
Book Value
$2.21 per share

Profitability

Net Income
$-60.97 million
Pretax Margin
-8,282.36%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$561.17 million
Optionable
Not Optionable

Company Calendar

Last Earnings
9/09/2021
Today
11/27/2021
Next Earnings (Estimated)
11/30/2021
Fiscal Year End
12/31/2021

MarketRank

Overall MarketRank

1.73 out of 5 stars

Medical Sector

889th out of 1,391 stocks

Pharmaceutical Preparations Industry

423rd out of 669 stocks

Analyst Opinion: 3.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -












BeyondSpring (NASDAQ:BYSI) Frequently Asked Questions

Is BeyondSpring a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BeyondSpring in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BeyondSpring stock.
View analyst ratings for BeyondSpring
or view top-rated stocks.

How has BeyondSpring's stock price been impacted by Coronavirus?

BeyondSpring's stock was trading at $11.35 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, BYSI stock has increased by 26.4% and is now trading at $14.35.
View which stocks have been most impacted by COVID-19
.

Are investors shorting BeyondSpring?

BeyondSpring saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 4,630,000 shares, an increase of 20.3% from the September 30th total of 3,850,000 shares. Based on an average daily trading volume, of 3,470,000 shares, the days-to-cover ratio is presently 1.3 days. Currently, 22.5% of the shares of the stock are short sold.
View BeyondSpring's Short Interest
.

When is BeyondSpring's next earnings date?

BeyondSpring is scheduled to release its next quarterly earnings announcement on Tuesday, November 30th 2021.
View our earnings forecast for BeyondSpring
.

How were BeyondSpring's earnings last quarter?

BeyondSpring Inc. (NASDAQ:BYSI) posted its earnings results on Thursday, September, 9th. The company reported ($0.49) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.49). The company had revenue of $0.34 million for the quarter, compared to analysts' expectations of $13.84 million. During the same quarter in the prior year, the business posted ($0.46) earnings per share.
View BeyondSpring's earnings history
.

What price target have analysts set for BYSI?

5 brokers have issued 1 year price objectives for BeyondSpring's stock. Their forecasts range from $25.00 to $95.00. On average, they anticipate BeyondSpring's stock price to reach $58.75 in the next year. This suggests a possible upside of 309.4% from the stock's current price.
View analysts' price targets for BeyondSpring
or view top-rated stocks among Wall Street analysts.

Who are BeyondSpring's key executives?

BeyondSpring's management team includes the following people:
  • Lan Huang, Chairman & Chief Executive Officer
  • Richard J. Daly, Chief Operating Officer
  • Elizabeth Adkins Czerepak, Chief Financial Officer
  • G. Kenneth Lloyd, Chief Scientific Officer
  • Ramon W. Mohanlal, Director, Chief Medical Officer, Executive VP-R&D

What other stocks do shareholders of BeyondSpring own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BeyondSpring investors own include Exelixis (EXEL), Gilead Sciences (GILD), Sorrento Therapeutics (SRNE), AbbVie (ABBV), Enterprise Products Partners (EPD), Johnson & Johnson (JNJ), Pfizer (PFE), Atara Biotherapeutics (ATRA), CorMedix (CRMD) and Dynavax Technologies (DVAX).

When did BeyondSpring IPO?

(BYSI) raised $4 million in an initial public offering on Thursday, March 9th 2017. The company issued 200,000 shares at $20.00 per share. Rodman & Renshaw (a Unit of H.C. Wainwright & Co.) served as the underwriter for the IPO.

What is BeyondSpring's stock symbol?

BeyondSpring trades on the NASDAQ under the ticker symbol "BYSI."

Who are BeyondSpring's major shareholders?

BeyondSpring's stock is owned by a variety of retail and institutional investors. Top institutional investors include Alliancebernstein L.P. (7.56%), BlackRock Inc. (4.10%), Morgan Stanley (1.16%), Two Sigma Investments LP (0.84%), Tanaka Capital Management Inc. (0.82%) and Citadel Advisors LLC (0.00%).

Which institutional investors are selling BeyondSpring stock?

BYSI stock was sold by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Apis Capital Advisors LLC, California State Teachers Retirement System, Russell Investments Group Ltd., CNA Financial Corp, and The Manufacturers Life Insurance Company .

Which institutional investors are buying BeyondSpring stock?

BYSI stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, Two Sigma Investments LP, Millennium Management LLC, Sectoral Asset Management Inc, Citadel Advisors LLC, BlackRock Inc., Voloridge Investment Management LLC, and Barclays PLC.

How do I buy shares of BeyondSpring?

Shares of BYSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BeyondSpring's stock price today?

One share of BYSI stock can currently be purchased for approximately $14.35.

How much money does BeyondSpring make?

BeyondSpring has a market capitalization of $561.17 million and generates $180 thousand in revenue each year. The company earns $-60.97 million in net income (profit) each year or ($1.93) on an earnings per share basis.

How many employees does BeyondSpring have?

BeyondSpring employs 91 workers across the globe.

What is BeyondSpring's official website?

The official website for BeyondSpring is www.beyondspringpharma.com.

Where are BeyondSpring's headquarters?

BeyondSpring is headquartered at 28 LIBERTY STREET 39TH FLOOR, NEW YORK NY, 10005.

How can I contact BeyondSpring?

BeyondSpring's mailing address is 28 LIBERTY STREET 39TH FLOOR, NEW YORK NY, 10005. The company can be reached via phone at (646) 305-6387, via email at [email protected], or via fax at 1-646-882-4228.


This page was last updated on 11/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.